Table 1.
Clinical characteristics of patients with BT-IPMN
| Demographics | n | UICC stage (n= 17) | n |
| Age (median years; range) | 68 (31–81) | Intra-hepatic (n= 3) | |
| Male gender (%) | 10 (48) | I | 1 |
| II | 1 | ||
| Presenting symptoms | n (%) | IIIA | 0 |
| Abdominal discomfort | 15 (65) | IIIB | 0 |
| Jaundice | 9 (39) | IIIC | 1 |
| Weight loss | 8 (35) | IV | 0 |
| Extra-hepatic (n= 14) | |||
| Lesion location | n (%) | IA | 8 |
| Extra-hepatic | 17 (52) | IB | 2 |
| Hilar | 5 (22) | IIA | 1 |
| Non-hilar | 12 (52) | IIB | 3 |
| Intra-hepatic | 6 (26) | III | 0 |
| IV | 0 | ||
| Procedure types | n (%) | ||
| Pancreatoduodenectomy | 6 | Pre-operative labs (serum) | Median (range) |
| Hepatic & BD resection | 6 | Total bilirubin (mg/dL) | 3.2 (0.4–15.6) |
| BD resection only | 5 | Alk. Phos. (U/l) | 501 (162–1409) |
| Hepatic resection | 5 | ||
| Lobectomy | 4 | ||
| Segmentectomy | 1 | ||
| Cholecystectomy | 1 |